LIRILUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 06:43:28 GMT 2023` Edited by `admin` on `Sat Dec 16 06:43:28 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	S9XDI9W918
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LIRILUMAB

Official Name

English

BMS-986015-01

Code

English

IMMUNOGLOBULIN G4, ANTI-(HUMAN ANTIGEN RECEPTOR KIR (KILLER CELL IMMUNOGLOBULIN-LIKE)) (HUMAN MONOCLONAL ANTI-KIR(CHO) HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ANTI-KIR(CHO) LIGHT CHAIN, DIMER

Systematic Name

English

IPH-2102

Code

English

IPH2102

Code

English

LIRILUMAB [USAN]

Common Name

English

lirilumab [INN]

Common Name

English

ANTI-KIR ANTIBODY

Code

English

BMS-986015

Code

English

Lirilumab [WHO-DD]

Common Name

English

BMS-98601501

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C129822

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

NCI_THESAURUS

C141144

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

Code System Code Type Description

DRUG BANK

DB11754

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

ChEMBL

CHEMBL2109500

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

CAS

1000676-41-4

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

WIKIPEDIA

Lirilumab

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

INN

9415

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

FDA UNII

S9XDI9W918

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

USAN

ZZ-164

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

NCI_THESAURUS

C103820

Created by admin on Sat Dec 16 06:43:28 GMT 2023 , Edited by admin on Sat Dec 16 06:43:28 GMT 2023

PRIMARY

From	To
1_22	1_96
1_150	1_206
1_264	1_324
1_370	1_428
2_22	2_96
2_150	2_206
2_264	2_324
2_370	2_428
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_137	3_214
2_137	4_214
1_229	2_229
1_232	2_232

Glycosylation Link Type	Site
N	1_300
N	2_300

Related Record Type Details


					S9XDI9W918

LIRILUMAB

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL